tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2024-012tumors-1410Research ArticleОБЗОРЫ И АНАЛИТИКАREVIEWS AND ANALYSISАнгиосаркома молочной железы (обзор литературы и описание двух клинических наблюдений)Angiosarcoma of the breast (literature review and description of two clinical observations)https://orcid.org/0000-0003-4447-9458ОрловаР. В.OrlovaR. V.

Орлова Рашида Вахидовна

199034 Санкт-Петербург, Университетская наб., 7-94 198255 Санкт-Петербург, пр-кт Ветеранов, 56

Orlova Rashida Vakhidovna

7-9 universitetskaya Naberezhnaya, Saint Petersburg 199034; 56 Veteranov Prospekt, Saint Petersburg 198255

https://orcid.org/0000-0001-7111-1507АндросоваА. В.AndrosovaA. V.

Андросова Александра Валерьевна

198255 Санкт-Петербург, пр-кт Ветеранов, 56

Androsova Aleksandra Valerevna

56 Veteranov Prospekt, Saint Petersburg 198255

alexa.androsova.1711@mail.ruhttps://orcid.org/0000-0002-2105-2251ТопузовЭ. Э.TopuzovE. E.

Топузов Эльдар Эскендерович

198255 Санкт-Петербург, пр-кт Ветеранов, 56; 191015 Санкт-Петербург, ул. Кирочная, 41

Topuzov Eldar Eskenderovich

56 Veteranov Prospekt, Saint Petersburg 198255; 41 Kirochnaya St., Saint Petersburg 191015

https://orcid.org/0000-0003-0402-6067БелякН. П.BelyakN. P.

Беляк Наталья Петровна

199034 Санкт-Петербург, Университетская наб., 7-94 198255 Санкт-Петербург, пр-кт Ветеранов, 56

Belyak Natalya Petrovna

7-9 Universitetskaya Naberezhnaya, Saint Petersburg 199034; 56 Veteranov Prospekt, Saint Petersburg 198255

https://orcid.org/0000-0003-2221-4088КутуковаС. И.KutukovaS. I.

Кутукова Светлана Игоревна

198255 Санкт-Петербург, пр-кт Ветеранов, 56;197022 Санкт-Петербург, ул. Льва Толстого, 6-8

Kutukova Svetlana Igorevna

56 Veteranov Prospekt, Saint Petersburg 198255; 197022 Санкт-Петербург, ул. Аъеа Толстого, 6—8

АвраменкоИ. В.AvramenkoI. V.

198255 Санкт-Петербург, пр-кт Ветеранов, 56

56 Veteranov Prospekt, Saint Petersburg 198255

https://orcid.org/0000-0003-0211-9809ИвановаА. К.IvanovaA. K.

Иванова Анастасия Константиновна

198255 Санкт-Петербург, пр-кт Ветеранов, 56

Ivanova Anastasiya Konstantinovna

56 Veteranov Prospekt, Saint Petersburg 198255

ВаранкинаА. А.VarankinaA. A.

198255 Санкт-Петербург, пр-кт Ветеранов, 56

56 Veteranov Prospekt, Saint Petersburg 198255

КоркинаА. А.KorkinaA. A.

198255 Санкт-Петербург, пр-кт Ветеранов, 56

56 Veteranov Prospekt, Saint Petersburg 198255

РахимоваГ. А.RakhimovaG. A.

197022 Санкт-Петербург, ул. Льва Толстого, 6-8

197022 Санкт-Петербург, ул. Аъеа Толстого, 6—8

ФГБОУ ВО «Санкт-Петербургский государственный университет»; СПб ГБУЗ «Городской клинический онкологический Диспансер»РоссияSaint Petersburg State University; City Clinical Oncological DispensaryRussian FederationСПб ГБУЗ «Городской клинический онкологический Диспансер»РоссияCity Clinical Oncological DispensaryRussian FederationСПб ГБУЗ «Городской клинический онкологический Диспансер»; ГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава РоссииРоссияCity Clinical Oncological Dispensary; I. I. Mechnikov North-West State Medical University, Ministry of Health of RussiaRussian FederationСПб ГБУЗ «Городской клинический онкологический Диспансер»; ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова»РоссияCity Clinical Oncological Dispensary; Academician I. P. Pavlov First St. Petersburg State Medical UniversityRussian FederationФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова»РоссияAcademician I. P. Pavlov First St. Petersburg State Medical UniversityRussian Federation2024181220241434955Copyright © Орлова Р.В., Андросова А.В., Топузов Э.Э., Беляк Н.П., Кутукова С.И., Авраменко И.В., Иванова А.К., Варанкина А.А., Коркина А.А., Рахимова Г.А., 20242024Орлова Р.В., Андросова А.В., Топузов Э.Э., Беляк Н.П., Кутукова С.И., Авраменко И.В., Иванова А.К., Варанкина А.А., Коркина А.А., Рахимова Г.А.Orlova R.V., Androsova A.V., Topuzov E.E., Belyak N.P., Kutukova S.I., Avramenko I.V., Ivanova A.K., Varankina A.A., Korkina A.A., Rakhimova G.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/1410

Ангиосаркома молочных желез представляет собой редкое злокачественное заболевание, которое составляет менее 0,5% от всех случаев рака молочной железы. Характеризуется заболевание быстрым ростом, агрессивным течением, активной диссеминацией процесса и плохим ответом на лечение. Особенность заболевания состоит в сложности диагностики процесса, поскольку клиническая картина не является специфической и зачастую протекает под маской кожных заболеваний, такие как экзема, атопический дерматит, розацеа и т. д. Ведущим звеном лечения данного заболевания является хиругическое лечение. В данной статье представлен собственный опыт ведения пациентов с ангиосаркомами молочных желез, возникших после лечения карциномы молочной железы в СПб ГБУЗ ГКОД.

Breast angiosarcoma is a rare malignancy that accounts for less than 0.5% of all breast cancers. The disease is characterized by rapid growth, aggressive course, active dissemination of the process and poor response to treatment. The peculiarity of the disease lies in the complexity of diagnosing the process, since the clinical picture is not specific and often occurs under the guise of skin diseases such as eczema, atopic dermatitis, rosacea, etc. Also, the complexity of diagnosis is complemented by the lack of specific imaging methods, thanks to which it would be possible to diagnose angiosarcoma with high accuracy. The leading element of treatment is a combined approach, namely a combination of surgical excision, drug therapy and radiation. This article presents our own experience in managing a patient with angiosarcoma of the right breast, which arose 7 years after the treatment of breast carcinoma in the St. Petersburg City Clinical Oncology Center.

ангиосаркомамолочная железарадиоиндуцированная ангиосаркомаangiosarcomabreastradiation inducedangiosarcomaСтатья подготовлена без спонсорской поддержкиThe article was prepared without sponsorshipReferencesVirgilio E., Lombardi M., Stefano D.D., et al. Angiosarcoma of the breast: a rare and dismal complication of breast surgery associated with radiation. Am Surg 2017;83(3):e71-73Virgilio E., Lombardi M., Stefano D.D., et al. Angiosarcoma of the breast: a rare and dismal complication of breast surgery associated with radiation. Am Surg 2017;83(3):e71-73Farran Y., Padilla O., Chambers K., et al. Atypical presentation of radiation-associated breast angiosarcoma: a case report and review ofliterature. AmJ Case Rep 2017;18:1347-1350. https://doi.org/10.12659/ajcr.905157Farran Y., Padilla O., Chambers K., et al. Atypical presentation of radiation-associated breast angiosarcoma: a case report and review ofliterature. AmJ Case Rep 2017;18:1347-1350. https://doi.org/10.12659/ajcr.905157Mergancova J., Lierova A., Coufal O., et al. Radiation-associated angiosarcoma of the breast: An international multicenter analysis. Surg Oncol 2022;41:101726. https://doi.Org/10.1016/j.suronc.2022.101726Mergancova J., Lierova A., Coufal O., et al. Radiation-associated angiosarcoma of the breast: An international multicenter analysis. Surg Oncol 2022;41:101726. https://doi.Org/10.1016/j.suronc.2022.101726Ribeiro M.F., Soroka H.P., Bhura Z., et al. Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study. Ther Adv Med Oncol 2023;15:17588359231198943. https://doi.org/10.1177/17588359231198943Ribeiro M.F., Soroka H.P., Bhura Z., et al. Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study. Ther Adv Med Oncol 2023;15:17588359231198943. https://doi.org/10.1177/17588359231198943Рябчиков Д.А., Воротников И.К., Чхиквадзе H.B. и соавт. Саркомы молочной железы. Обзор литературы. Опухоли женской репродуктивной системы. 2014;(2):12-15. https://doi.org/10.17650/1994-4098-2014-0-2-12-15.Ryabchikov D.A., Vorotnikov I.K., Chkhikvadze N.V., et al. Breast sarcomas. Literature review. Tumors of female reproductive system. 2014;(2):12—15 (In Russ.), https://doi.org/10.17650/1994-4098-2014-0-2-12-15Salminen S.H., Wiklund T., Sampo M.M., et al. Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population. Ann Surg Oncol 2020;27(4):1002-1010. https://doi.org/10.1245/sl0434-019-08085-lSalminen S.H., Wiklund T., Sampo M.M., et al. Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population. Ann Surg Oncol 2020;27(4):1002-1010. https://doi.org/10.1245/sl0434-019-08085-lShah S., Rosa M. Radiation-associated angiosarcoma of the breast: clinical and pathologic features. Arch Pathol Lab Med2016;140(5):477-481. https://doi.org/10.5858/arpa.2014-0581-RSShah S., Rosa M. Radiation-associated angiosarcoma of the breast: clinical and pathologic features. Arch Pathol Lab Med2016;140(5):477-481. https://doi.org/10.5858/arpa.2014-0581-RSChikarmane S.A., Combos E.C., Jagadeesan J. Et al. MRI findings of radiation-associated angiosarcoma of the breast (RAS). J Magn Reson Imaging 2015;42(3):763-770. https://doi.org/10.1002/jmri.24822Chikarmane S.A., Combos E.C., Jagadeesan J. Et al. MRI findings of radiation-associated angiosarcoma of the breast (RAS). J Magn Reson Imaging 2015;42(3):763-770. https://doi.org/10.1002/jmri.24822Cahan W.G., Woodard H.Q., Higinbotham N.L. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1948;l(l):3-29. https://doi.org/10.1002/1097-0142(194805)l:l<3::aid-cncr2820010103>3.0.co;2-7Cahan W.G., Woodard H.Q., Higinbotham N.L. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1948;l(l):3-29. https://doi.org/10.1002/1097-0142(194805)l:l<3::aid-cncr2820010103>3.0.co;2-7Feinberg L., Srinivasan A., Singh J.K., et al. Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. BrJ Surg 2018;105(4):401-409. https://doi.org/10.1002/bjs.10696Feinberg L., Srinivasan A., Singh J.K., et al. Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. BrJ Surg 2018;105(4):401-409. https://doi.org/10.1002/bjs.10696Dufresne A., Meeus P., Sunyach M.P. Treatment of radiation-associated angiosarcoma. Curr Opin Oncol 2023;35(4):296— 300. https://doi.org/10.1097/CCO.0000000000000958Dufresne A., Meeus P., Sunyach M.P. Treatment of radiation-associated angiosarcoma. Curr Opin Oncol 2023;35(4):296— 300. https://doi.org/10.1097/CCO.0000000000000958Bonito F.J.P., de Almeida Cerejeira D., Dahlstedt-Ferreira C., et al. Radiation-induced angiosarcoma of the breast: Areview. BreastJ 2020;26(3):458-463. https://doi.org/10.llll/tbj.13504Bonito F.J.P., de Almeida Cerejeira D., Dahlstedt-Ferreira C., et al. Radiation-induced angiosarcoma of the breast: Areview. BreastJ 2020;26(3):458-463. https://doi.org/10.llll/tbj.13504Monroe A.T., Feigenberg S.J., Mendenhall N.P. Angiosarcoma after breast-conserving therapy. Cancer 2003;97(8):18321840. https://doi.org/10.1002/cncr.11277Monroe A.T., Feigenberg S.J., Mendenhall N.P. Angiosarcoma after breast-conserving therapy. Cancer 2003;97(8):18321840. https://doi.org/10.1002/cncr.11277Takehara Y., Matsuda N., Kobayashi D., et al. Radiation-induced angiosarcoma of the breast: individual participant meta-analysis ofjapanese population. Breast Cancer 2023;30(5):739-747. https://doi.org/10.1007/sl2282-023-01466-lTakehara Y., Matsuda N., Kobayashi D., et al. Radiation-induced angiosarcoma of the breast: individual participant meta-analysis ofjapanese population. Breast Cancer 2023;30(5):739-747. https://doi.org/10.1007/sl2282-023-01466-lSalminen S.H., Sampo M.M., Bohling T.O., et al. Radiation-associated angiosarcoma of the breast: analysis of diagnostic tools in aregistry-basedpopulation. Acta Radiol 2022;63(l):22-27. https://doi.org/10.1177/0284185120980142Salminen S.H., Sampo M.M., Bohling T.O., et al. Radiation-associated angiosarcoma of the breast: analysis of diagnostic tools in aregistry-basedpopulation. Acta Radiol 2022;63(l):22-27. https://doi.org/10.1177/0284185120980142Suzuki Y., Taniguchi K., Hatono M., et al. Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report. Surg Case Rep 2020;6(l):25. https://doi.org/10.1186/s40792-020-0790-7Suzuki Y., Taniguchi K., Hatono M., et al. Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report. Surg Case Rep 2020;6(l):25. https://doi.org/10.1186/s40792-020-0790-7Cohen-Hallaleh R.B., Smith H.G., Smith R.C., et al. Radiation induced angiosarcoma of the breast: outcomes from aretrospective case series. Clin Sarcoma Res 2017;7:15. https://doi.org/10.1186/sl3569-017-0081-7Cohen-Hallaleh R.B., Smith H.G., Smith R.C., et al. Radiation induced angiosarcoma of the breast: outcomes from aretrospective case series. Clin Sarcoma Res 2017;7:15. https://doi.org/10.1186/sl3569-017-0081-7Smith T.L., Morris C.G., Mendenhall N.P. Angiosarcoma after breastconserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART). Acta Oncol 2014;53(2):235-241. https://doi.org/10.3109/0284186X.2013.819117Smith T.L., Morris C.G., Mendenhall N.P. Angiosarcoma after breastconserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART). Acta Oncol 2014;53(2):235-241. https://doi.org/10.3109/0284186X.2013.819117Agulnik M., Yarber J.L., Okuno S.H., et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 2013;24(l):257-63. https://doi.org/10.1093/annonc/mds237Agulnik M., Yarber J.L., Okuno S.H., et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 2013;24(l):257-63. https://doi.org/10.1093/annonc/mds237Ray-Coquard I.L., Domont J., Tresch-Bruneel E., et al. Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase II trial. J Clin Oncol 2015;33(25):2797-802. https://doi.org/10.1200/JC0.2015.60.8505Ray-Coquard I.L., Domont J., Tresch-Bruneel E., et al. Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase II trial. J Clin Oncol 2015;33(25):2797-802. https://doi.org/10.1200/JC0.2015.60.8505van der Graaf W.T., Blay J.Y., Chawla S.P., et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379(9829):1879-86. https://doi.org/10.1016/S0140-6736(12)60651-5van der Graaf W.T., Blay J.Y., Chawla S.P., et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379(9829):1879-86. https://doi.org/10.1016/S0140-6736(12)60651-5Kollar A., Jones R.L., Stacchiotti S, et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncol 2017;56(l):88-92. https://doi.org/10.1080/0284186X.2016.1234068Kollar A., Jones R.L., Stacchiotti S, et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncol 2017;56(l):88-92. https://doi.org/10.1080/0284186X.2016.1234068Woll P.J., Gaunt P., Gaskell C., et al. Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata. Br J Cancer 2023;129(9):1490-1499. https://doi.org/10.1038/s41416-023-02416-6.Woll P.J., Gaunt P., Gaskell C., et al. Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata. Br J Cancer 2023;129(9):1490-1499. https://doi.org/10.1038/s41416-023-02416-6.

The authors declare that there are no conflicts of interest present.